Close Menu

NEW YORK – Luminex reported on Sunday an 11 percent year-over-year increase in its preliminary fourth quarter revenues.

For Q4 2019, the Austin, Texas-based company recorded $90.4 million in revenues compared to $81.1 million in revenues in the year-ago period. The revenue figure misses the consensus Wall Street estimate of $91.2 million.

Luminex said it anticipates it will be profitable for Q4 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.